At the commencement of the trading day, Spruce Biosciences, Inc. (NASDAQ: SPRB) disclosed its fourth quarter financial outcomes.
The company revealed a decrease in earnings compared to the previous year, as well as a decline in revenues.
The company posted a quarterly net loss of $0.57 per share, with reported revenue totaling $0.7 million.
Analysts had projected a quarterly loss of $0.18 per share and forecasted revenue of $0.5 million.
The quarterly results displayed a 147.8 percent drop in earnings and a 75.9 percent decrease in revenue from the prior year.
